Amendments To The Cabinet Of Ministers Of 5 January 1999, Regulation No 7 Of The "procedure For Registration Of Infectious Diseases"

Original Language Title: Grozījumi Ministru kabineta 1999.gada 5.janvāra noteikumos Nr.7 "Infekcijas slimību reģistrācijas kārtība"

Read the untranslated law here: https://www.vestnesis.lv/ta/id/132356

Cabinet of Ministers Regulations No. 260 in 2006 (April 4. No 19 36) amendments to the Cabinet of Ministers of 5 January 1999, regulations No 7 "infectious disease registration order" Issued in accordance with the epidemiological safety law of article 10 and article 14, paragraph 4 of the first paragraph to make the Cabinet of Ministers of 5 January 1999, regulations No 7 "order of registration of infectious diseases" (Latvian journal, 1999, 5/6.nr.; 2002, 97. nr.; 2003, 111 no; 2004, nr. 66) the following amendments: 1. Express 3 the following : "3. the laboratory of infectious diseases and infectious disease agents found records of competency in accordance with the provisions of annex 2 and 3 provide: 3.1 the public health agency and its territorial departments; 3.2. Sexually transmitted skin disease and a public agency; 3.3. the AIDS Prevention Center; 3.4. the tuberculosis and lung disease, a government agency. " 2. Delete paragraph 5. 3. the introductory part of paragraph 6 Worded as follows: "6. If medical treatment person observed that a patient is in annex 2 of these provisions that a communicable disease, or have professional a reasonable suspicion about the patient being infected with these rules referred to in annex 2 of the disease, treatment of persons in accordance with the provisions of paragraph 7 of the report:". 4. Delete paragraph 6.4. 5. Express 6.5. subparagraph by the following: "6. vaccination against rabies course designation, completion or cessation (if patient bitten, scratched or apsiekaloj by the animal)." 6. To express the point 7 by the following: "7. If a communicable disease is detected or occur in professionally reasonable suspicion about the patient being infected with infectious diseases, treatment of persons: 7.1 for this rule group 1 of annex 2 of the diseases referred to shall be notified immediately to the Agency's public health branch any time of the day by telephone and in writing by sending a completed urgent notification form and registering the fact of reporting infectious diseases Journal of accounting according to the legislation on medical records filing procedures; 7.2. the provisions of this annex 2 Group 2 of the diseases listed in the report to the public health agency's branch in 24 hours by telephone and in writing by sending a completed urgent notification form and registering the fact of reporting infectious diseases Journal of accounting according to the legislation on medical records filing procedures; 7.3. Annex 2 to these rules in the Group 3 of the diseases reported in writing to the public health agency's branch, sexually transmitted and skin diseases, the National Agency for AIDS prevention centre or the tuberculosis and lung disease state agency not later than 72 hours, sending fill the urgent notification form and registering the fact of reporting infectious diseases Journal of accounting according to the legislation on medical records filing procedure. " 7. To supplement the provisions under 7.1, 7.2 and 7.3 of the paragraph as follows: "If potential infectious disease 7.1 first established emergency medical teams in the medical person, it gives the urgent notification only for hospitalizētaj not persons. If the person hospitaliz and possible infectious disease diagnosis is not canceled, the urgent communication to provide hospital treatment admissions office in person. 7.2 these terms before reporting in paragraph 3, the said institutions shall inform the person of the person's medical treatment for which it is reported, indicating the purpose of reporting and acknowledging the urgent notification form information provided will only be used for epidemiological surveillance. If the person on whom it is reported, is a minor or incapacitated, the Court recognized it, inform the person of the legal representative. 7.3 educational, social care institutions or other institutions Manager supports the provision of information by telephone to the public health agency's branch, where he suspected the presence of a block (the institution is two (or more) people with such infectious disease symptoms — diarrhea, vomiting, skin, mucous membranes or eyes of jaundice, increased body temperature, rashes or other skin disorder). " 8. Make paragraph 10 by the following: "10." Microbiology Laboratory Manager or his authorised person of the public health agency's branch reported: 10.1. about this rule referred to in annex 2 of dangerous infectious disease agent identification in any human, animal or environmental sample materials, immediately by telephone, registering the fact of reporting infectious diseases Journal of accounting according to the legislation on medical records filing procedures; 10.2. these rules referred to in annex 2 infectious disease agent identification checked samples of human material, if used in annex 3 of the infectious disease agent identification methods, not later than 24 hours, sending fill the urgent notification form and registering the fact of reporting infectious diseases Journal of accounting according to the legislation on medical records filing procedure. " 9. Delete paragraph 12. 10. Amend Annex 1, 2, 6, 10, 18 and 23 points. 11. To supplement annex 1 to 25, 26 and 27 the following: "25. Plague 26. Vibriosis 27. Avian influenza or other newly appeared dangerous zoonotic disease". 12. To make the annex by the following: "2. the annex to Cabinet of Ministers of 5 January 1999, regulations No 7 Recorded in infectious disease and medical institutions shall report on the person they no PO box recorded group of communicable diseases communicable disease epidemiological surveillance of institutions of public health agencies and the branch's sexually transmitted skin disease state agency AIDS Prevention Centre for tuberculosis and lung disease, the National Agency for acute flaccid paralysis in 1 children up to 15 years of age-2 + 2. Acute intestinal diseases except not infectious etiology diseases 2. + 3. Anisakioz 3. + 4. Anoģenitāl herpes infection in 3.

+ 5.3 + 6. Askaridoz type b Haemophilus influenza a infection 2. + 7.1 + Buck 8. Brucellosis 2. + 9. Human immunodeficiency virus (HIV) infection and AIDS 3.

+ 10.3 + 11 cysticercosis. other newly emerged a dangerous infectious disease * 1. + 12. Dermatofitoz (mikrosporij, trihofitij) 3.

+ 13.3 + 14 Difilobotrioz diphtheria and diphtheria agents carrying 2 + 15. Yellow fever + 1.16.

Animal bites, scratching you or apsiekalošan, if assigned, completed, or aborted immunization against rabies 2. + 17. Enterohaemorrhagic Escherichia coli in the proposed ešerihioz, urēmisk syndrome, haemolytic or trombocitār in haemorrhagic Purple 2. + 18. + 19. Echinococcosis 3. Mumps 2. + 20. the lice Epidemic typhus and Brill's disease * 1 + 21. Tick vīrusencefalīt + 2 Ērlihioz + 3 22 23. Pertussis 2. + 24. Gonococcal infection 3.

+ 25. Hantavīrus. 2 + infection Chlamydia proposed 26. sexually transmitted diseases 3.

+ 27. Cholera and cholera agent carrying 1 + glanders and melioidosis 28.2. + 29.2 + 30 yersiniosis. Campylobacter 2. + 3.31. Scabbers

+ 32. Variant Creutzfeldt-Jakob disease 3.33 +. 2. + 34 Cryptosporidiosis. Lyme disease. 3 + 35. Legionnaires ' disease 2. + 36. Leprosy 3.

+ 37.38 + 2. Leptospirosis Liesassērg (Siberian cattle plague) * 1. + 2.39. Listeriosis + 40. Malaria and the malaria agent carrying a 2. + 41. Measles 2. + 42. Rubella (t.sk. indigenous rubella syndrome) 2 + 43. Meningitis, encephalitis 2. + 44. Meningococcal Infection 2. + 1.45. Fever + 46. Foot-and-mouth disease 2. + 47. Ornithosis (psittacosis) 2. + 48. Polio 1 + 49. Avian influenza 1 + 50.2 + West Nile fever 51. Q-fever and other riketsioz 2. + 52. they cause salmonellosis and carrying 2 + 53. Syphilis , t.sk. congenital syphilis syndrome 3.

+ 54.55 + 2. Scarlet fever, severe acute respiratory syndrome (SARS) 1 + 56. Tetanus (per) 2 + 57. Shigellosis and their agents carrying 2. + 3. Tenioz + 58.59. Toxoplasmosis 3. + 1.60. Rabies + 61.2. + 62 trichinosis. Trihiruāz (trihocefaloz) 3 + 63. Tuberculosis 3.


+ 64.65.2 + Tularemia So atguļ of the fever 66.1 + nutrition toksikoinfekcij (t.sk. botulism) 2 + 67. Typhoid, paratyphoid and t.sk. typhoid and paratyphoid germs over 2 + 68. Chicken pox 2. + 69. Viral hepatitis, t.sk. hepatitis virus carrying 2 + 70. Viral haemorrhagic fevers, URt.sk.: Ebola vīrusslimīb, Lassa fever, Marburg, vīrusslimīb of Crimean Congo haemorrhagic fever 1. + Žiardiāz. + 71.3 Note. * Dangerous communicable diseases. " 13. To supplement the provisions of annex 3 with the following: "3. the Cabinet of Ministers of 5 January 1999, regulations No 7 predetermines laboratory findings infectious pathogens and their detection methods no PO box cause infectious disease and infectious disease Pathogen detection method 1. Bacterial infectious diseases 1.1. Bordetella pertussis (whooping cough) specific long cough response detection of antibodies, if no vaccinations have been carried out recently. Nucleic acid detection. Bordetella pertussis from clinical specimen Corynebacterium diphtheriae 1.2 or Corynebacterium Cyst (diphtheria and diphtheria agents carrying) produced the toxin of korinobaktērij (typical of c. diphtheriae or c. cyst) from a clinical specimen 1.3. Campylobacter species Campylobacter SP. (Campylobacter) from a clinical sample 1.4. Escherichia coli O157 serogrup: O26, O111, O145, and others (of Enterohaemorrhagic Escherichia coli (EHEC) proposed ešerihioz) e. coli, which belongs to the serogrup, cause Enterohaemorrhagic disease (O-157; O-26; O-111; O-103; O-145; O-48). Positive serological tests in patients with urēmisk syndrome, haemolytic or trombocitār in haemorrhagic purple. A tentative case-finding, the gene that coded for the production of Stx1/Stx2 1.5. Haemophilus influenza (type B Haemophilus influenza a infection) h. influenza type B from a normally sterile clinical material. H. influenza a nucleic acid from normally sterile clinical material. In the case of suspicion-h. detection of h. influenzae Antigen from normally sterile clinical material in the 1.6-pneumophil Legionell (Legionnaires ' disease) of the micro-organism Legionell from respiratory secretion, lung tissue or blood. Specific antibody responses against the pneumophil serogrup 1, Legionell, other serogroups or other species to establish Legionell indirect imūnfluorescenc of the antibody test or micro-agglutination reaction. The specific antigen of detection urine Legionell, using validated reagents. Probable case: a one-off high specific serum antibody titer against l. pneumophil 1. serogrup, other serogroups or other Legionell species; -Detection of specific antigen Legionell respiratory secretion or direct fluorescent antibody (DFA) staining of respiratory secretions or lung tissue using evaluated reagents 1.7. Listeria monocytogenes (listeriosis) Listeria monocytogenes from a normally sterile clinical material (e.g. blood or cerebrospinal fluid, joint, pleural or pericardial fluid) Methicillin-resistant S 1.8. aureus (MRSA), vancomycin-resistant s. aureus (BRING). S. pneumoniae with reduced susceptibility to penicillin (against antimikrob means of resistant infections caused by micro-organisms) Methicillin-resistant s. aureus and vancomycin-resistant or s. aureus from clinical material. S. pneumoniae with reduced susceptibility to penicillin extraction from a normally sterile clinical material Not isseri meningitidis of 1.9 (meningococcal infection) n. meningitidis from a normally sterile clinical material (e.g. blood or cerebrospinal fluid, joint, pleural or pericardial fluid). Detection of n. meningitidis nucleic acid detection normally sterile clinical material. N. meningitidis Antigen from normally sterile clinical material. Gramnegatīv for the detection of microscopic diplococci in normally sterile clinical material. Probable case: single high titre of meningococcal antibody in serum of rekonvalescenc in 1.10. Salmonella species (salmonellosis and the agents carrying), salmonella (typhoid fever, paratyphoid fever, not not) from a clinical specimen 1.11. Salmonella and Salmonella Typhi paratyphii (typhoid and paratyphoid fever, typhoid and paratyphoid t.sk. agents carrying) s. Typhi or paratyphii s. from blood, stool or other clinical material 1.12 species Shigella (Shigellosis and its agents carrying) Shigella sp. from a clinical specimen Streptococcus pneumoniae 1.13 (pneumococcal infection)

Isolation of s. pneumoniae from a normally sterile clinical material (e.g. blood or cerebrospinal fluid, joint, pleural or pericardial fluid). Detection of s. pneumoniae nucleic acid from normally sterile clinical material. A tentative case-detection of s. pneumoniae Antigen from a normally sterile clinical material 1.14. Vibrio cholerae non 01 serogrup (except 0139) and the Vibrio parahaemolyticus (vibriosis) agent from clinical material 1.15. Yersinia enterocolitica and Yersinia pseudotuberculos (yersiniosis) y. enterocolitica or Y pseudotubeculosis from a clinical specimen 2. Viral infectious disease 2.1. B19 parvovīrus (parvovīrus B19 infection) B19 IgM antibodies of parvovīrus detection. The ribonukleīnskāb of parvovīrus B19 (RNA) detection in clinical material in the mumps Epidemic 2.2 virus (mumps) epidemic mumps virus IgM antibody detection of epidemic mumps virus specific antibody detection, if no vaccinations have been carried out recently. Epidemic mumps virus (not vaccine strains) from clinical specimen isolation. Epidemic mumps virus RNA detection 2.3. Influenza virus (flu) influenza virus Antigen or specific RNA detection. Influenza virus isolations. Influenza a or B virus specific antibody response in serum detection 2.4. Measles virus (measles), measles virus IgM antibody detection, if no vaccinations have been carried out recently. Measles virus specific antibody response detection, if no vaccinations have been carried out recently. Measles virus (not vaccine strains) detection in the clinical sample 2.5. Rubella virus (rubella) rubella virus IgM antibody detection, if no vaccinations have been carried out recently. Rubella virus specific antibody response detection, if no vaccinations have been carried out recently. Rubella virus isolation, if no vaccinations have been carried out recently. Rubella virus RNA detection in the clinical sample 2.6. Viruses that cause acute enteric infections (such as rotavirus, a programme identifying norovirus, astrovīrus, 40 and 41 type adenovīrus) in the Specific virus Antigen detection in clinical material. Specific detection of viral RNA in clinical material 3. Parasitic infectious diseases of Balantidi coli 3.1 (balantidiāz) b. coli cyst detection of Entamoeb 3.2 histolytic stool (amebiāz) E histolytic's cyst detection. stool 3.3. Cryptosporid (Cryptosporidiosis) identification of Cryptosporid Oocyst intestināl liquid in the stool, or a thin gut biopsy sample. Cryptosporid determination of Oocyst Antigen stool 3.4. Cyclosporidi cayetanens (ciklosporidioz) of c. cayetanens the detection of stool or Oocyst nucleic acid from "Prime Minister a. Halloween Health Minister g. Smith